Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 35% ± 19% | |
intestine | 9 studies | 43% ± 21% | |
kidney | 6 studies | 33% ± 17% | |
uterus | 6 studies | 54% ± 20% | |
pancreas | 4 studies | 45% ± 18% | |
brain | 4 studies | 28% ± 16% | |
eye | 4 studies | 33% ± 16% | |
breast | 4 studies | 41% ± 8% | |
peripheral blood | 3 studies | 24% ± 4% | |
placenta | 3 studies | 28% ± 3% | |
ovary | 3 studies | 44% ± 28% | |
esophagus | 3 studies | 52% ± 20% | |
skin | 3 studies | 33% ± 17% | |
lymph node | 3 studies | 29% ± 3% | |
prostate | 3 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 82% | 37317.98 | 538 / 653 | 90% | 734.17 | 543 / 605 |
lung | 80% | 27748.40 | 464 / 578 | 79% | 238.46 | 913 / 1155 |
skin | 92% | 32362.77 | 1672 / 1809 | 66% | 198.73 | 310 / 472 |
ovary | 83% | 35816.60 | 150 / 180 | 74% | 295.92 | 319 / 430 |
prostate | 72% | 11555.45 | 176 / 245 | 85% | 580.66 | 429 / 502 |
breast | 83% | 27524.05 | 380 / 459 | 72% | 288.58 | 806 / 1118 |
esophagus | 67% | 16891.23 | 974 / 1445 | 84% | 286.46 | 153 / 183 |
kidney | 71% | 18061.97 | 63 / 89 | 73% | 406.11 | 656 / 901 |
bladder | 76% | 17262.48 | 16 / 21 | 67% | 180.97 | 336 / 504 |
uterus | 63% | 21814.19 | 107 / 170 | 79% | 277.10 | 363 / 459 |
stomach | 68% | 31535.33 | 243 / 359 | 74% | 201.92 | 211 / 286 |
intestine | 66% | 26441.27 | 635 / 966 | 73% | 213.79 | 387 / 527 |
adrenal gland | 67% | 13131.95 | 173 / 258 | 70% | 501.38 | 162 / 230 |
pancreas | 48% | 10364.06 | 157 / 328 | 87% | 308.28 | 155 / 178 |
liver | 49% | 8275.50 | 110 / 226 | 43% | 91.40 | 174 / 406 |
brain | 20% | 4825.04 | 520 / 2642 | 72% | 287.73 | 506 / 705 |
blood vessel | 87% | 36820.44 | 1165 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 357.65 | 39 / 45 |
adipose | 81% | 46049.18 | 970 / 1204 | 0% | 0 | 0 / 0 |
heart | 63% | 19372.08 | 540 / 861 | 0% | 0 | 0 / 0 |
muscle | 26% | 4544.41 | 208 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 24% | 28.01 | 7 / 29 |
spleen | 21% | 3132.28 | 51 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 13% | 21.37 | 10 / 80 |
peripheral blood | 6% | 658.04 | 52 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0044849 | Biological process | estrous cycle |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0071506 | Biological process | cellular response to mycophenolic acid |
GO_1901875 | Biological process | positive regulation of post-translational protein modification |
GO_0072303 | Biological process | positive regulation of glomerular metanephric mesangial cell proliferation |
GO_0002931 | Biological process | response to ischemia |
GO_0046886 | Biological process | positive regulation of hormone biosynthetic process |
GO_0033233 | Biological process | regulation of protein sumoylation |
GO_0009749 | Biological process | response to glucose |
GO_0045475 | Biological process | locomotor rhythm |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_2000182 | Biological process | regulation of progesterone biosynthetic process |
GO_0071504 | Biological process | cellular response to heparin |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0032868 | Biological process | response to insulin |
GO_0070498 | Biological process | interleukin-1-mediated signaling pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0072110 | Biological process | glomerular mesangial cell proliferation |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0043523 | Biological process | regulation of neuron apoptotic process |
GO_0071480 | Biological process | cellular response to gamma radiation |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0030217 | Biological process | T cell differentiation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0001666 | Biological process | response to hypoxia |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0060086 | Biological process | circadian temperature homeostasis |
GO_0035914 | Biological process | skeletal muscle cell differentiation |
GO_0098759 | Biological process | cellular response to interleukin-8 |
GO_0044029 | Biological process | positive regulation of gene expression via chromosomal CpG island demethylation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0044729 | Molecular function | hemi-methylated DNA-binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0010385 | Molecular function | double-stranded methylated DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0035035 | Molecular function | histone acetyltransferase binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | EGR1 |
Protein name | Early growth response protein Early growth response protein 1 (EGR-1) (AT225) (Nerve growth factor-induced protein A) (NGFI-A) (Transcription factor ETR103) (Transcription factor Zif268) (Zinc finger protein 225) (Zinc finger protein Krox-24) |
Synonyms | hCG_18777 ZNF225 KROX24 |
Description | FUNCTION: Transcriptional regulator . Recognizes and binds to the DNA sequence 5'-GCG(T/G)GGGCG-3'(EGR-site) in the promoter region of target genes (By similarity). Binds double-stranded target DNA, irrespective of the cytosine methylation status . Regulates the transcription of numerous target genes, and thereby plays an important role in regulating the response to growth factors, DNA damage, and ischemia. Plays a role in the regulation of cell survival, proliferation and cell death. Activates expression of p53/TP53 and TGFB1, and thereby helps prevent tumor formation. Required for normal progress through mitosis and normal proliferation of hepatocytes after partial hepatectomy. Mediates responses to ischemia and hypoxia; regulates the expression of proteins such as IL1B and CXCL2 that are involved in inflammatory processes and development of tissue damage after ischemia. Regulates biosynthesis of luteinizing hormone (LHB) in the pituitary (By similarity). Regulates the amplitude of the expression rhythms of clock genes: BMAL1, PER2 and NR1D1 in the liver via the activation of PER1 (clock repressor) transcription. Regulates the rhythmic expression of core-clock gene BMAL1 in the suprachiasmatic nucleus (SCN) (By similarity). . FUNCTION: Transcriptional regulator. Recognizes and binds to the DNA sequence 5'-GCG(T/G)GGGCG-3'(EGR-site) in the promoter region of target genes. Binds double-stranded target DNA, irrespective of the cytosine methylation status. Regulates the transcription of numerous target genes, and thereby plays an important role in regulating the response to growth factors, DNA damage, and ischemia. Plays a role in the regulation of cell survival, proliferation and cell death. . |
Accessions | Q546S1 ENST00000239938.5 P18146 |